CoChat

BAMBI Elimination Enhances Alternative TGF-β Signaling and Glomerular Dysfunction in Diabetic Mice

Open access
Fan, Ying, Li, Xuezhu, Xiao, Wenzhen, Fu, Jia, Harris, Ray C., Lindenmeyer, Maja, Cohen, Clemens D., Guillot, Nicolas, Baron, Margaret H., Wang, Niansong, Lee, Kyung, He, John C., Schlondorff, Detlef, Chuang, Peter Y. · 2015 · Diabetes

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.

Abstract

BMP, activin, membrane-bound inhibitor (BAMBI) acts as a pseudo-receptor for the transforming growth factor (TGF)-β type I receptor family and a negative modulator of TGF-β kinase signaling, and BAMBI−/− mice show mild endothelial dysfunction. Because diabetic glomerular disease is associated with TGF-β overexpression and microvascular alterations, we examined the effect of diabetes on glomerular BAMBI mRNA levels. In isolated glomeruli from biopsies of patients with diabetic nephropathy and in glomeruli from mice with type 2 diabetes, BAMBI was downregulated. We then examined the effects of BAMBI deletion on streptozotocin-induced diabetic glomerulopathy in mice. BAMBI−/− mice developed more albuminuria, with a widening of foot processes, than BAMBI+/+ mice, along with increased activation of alternative TGF-β pathways such as extracellular signal–related kinase (ERK)1/2 and Smad1/5 in glomeruli and cortices of BAMBI−/− mice. Vegfr2 and Angpt1, genes controlling glomerular endothelial stability, were downmodulated in glomeruli from BAMBI−/− mice with diabetes. Incubation of glomeruli from nondiabetic BAMBI+/+ or BAMBI−/− mice with TGF-β resulted in the downregulation of Vegfr2 and Angpt1, effects that were more pronounced in BAMBI−/− mice and were prevented by a MEK inhibitor. The downregulation of Vegfr2 in diabetes was localized to glomerular endothelial cells using a histone yellow reporter under the Vegfr2 promoter. Thus, BAMBI modulates the effects of diabetes on glomerular permselectivity in association with altered ERK1/2 and Smad1/5 signaling. Future therapeutic interventions with inhibitors of alternative TGF-β signaling may therefore be of interest in diabetic nephropathy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db14-1397

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

Metadata

Authors
Fan, Y., Li, X., Xiao, W., Fu, J., Harris, R. C., Lindenmeyer, M., Cohen, C. D., Guillot, N., Baron, M. H., Wang, N., Lee, K., He, J. C., Schlondorff, D., & Chuang, P. Y.
Affiliations
  • Shanghai Jiao Tong University (CN)
  • Icahn School of Medicine at Mount Sinai (US)
  • Vanderbilt University School of Medicine, Nashville, TN
  • University of Zurich (CH)
  • Tisch Cancer Institute (US)
  • Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY
Venue
Diabetes
Published
2015-01-09
Volume
64
Issue
6
Pages
2220-2233
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2120470379
Cited by
57
References
59
Citations by year
2026: 2 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 7 · 2019: 9 · 2018: 7 · 2017: 9 · 2016: 2 · 2015: 2
FWCI
5.76
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • U.S. Department of Veterans Affairs (I01 BX000320, I01BX000345)
  • National Heart, Lung, and Blood Institute (R01HL062248, HL-62248)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK051265, DK52191, R01DK078897, R01DK098126, R01DK088541, R01DK052191, R01DK062794, R01DK095785)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
Keywords
Bambi, TGF-beta signaling, diabetic nephropathy, diabetic glomerulopathy, VEGFR2, angiopoietin-1, ERK signaling, Smad1/5 signaling, albuminuria, glomerular permselectivity, type 2 diabetes, MEK inhibitors, TGF-beta type I receptor
MeSH terms
Animals, Humans, Kidney Glomerulus, Membrane Proteins, Blotting, Western, Signal Transduction, Transforming Growth Factor beta, Vascular Endothelial Growth Factor Receptor-2, Angiopoietin-1, Mice, Smad1 Protein, Smad5 Protein, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.